Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Steele

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Pharmacology|August 14, 2010
Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)N L Steele, J A Plumb, L Vidal, et al.
Oncogene|January 18, 2012
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profilingC Zeller, W Dai, N L Steele, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|August 14, 2010
Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)N L Steele, J A Plumb, L Vidal, et al.
Oncogene|January 18, 2012
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profilingC Zeller, W Dai, N L Steele, et al.
Pageof 1